Home LiteratureArticle Details
PMID: 1705569 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

In vitro and in vivo activation of endothelial cells by colony-stimulating factors.

The Journal of clinical investigation ·Vol. 87 ·No. 3 ·1991-03-00 ·Pages 986-95

Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, Bosia A, Marchisio PC, Mantovani A

Abstract

This study was designed to identify the set of functions activated in cultured endothelial cells by the hematopoietic growth factors, granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage-colony-stimulating factor (GM-CSF), and to compare them with those elicited by prototypic cytokines active on these cells. Moreover, indications as to the in vivo relevance of in vitro effects were obtained. G-CSF and GM-CSF induced endothelial cells to proliferate and migrate. In contrast, unlike appropriate reference cytokines (IL-1 and tumor necrosis factor, IFN-gamma), G-CSF and GM-CSF did not modulate endothelial cell functions related to hemostasis-thrombosis (production of procoagulant activity and of platelet activating factor), inflammation (expression of leukocyte adhesion molecule-1 and production of platelet activating factor), and accessory function (expression of class II antigens of MHC). Other colony-stimulating factors (IL-3 and macrophage-colony-stimulating factor) were inactive on all functions tested. In comparison to basic fibroblast growth factor (bFGF), G-CSF and GM-CSF induced lower maximal proliferation of endothelial cells, whereas migration was of the same order of magnitude. G-CSF and GM-CSF stimulated repair of mechanically wounded endothelial monolayers. Exposure to both cytokines induced shape changes and cytoskeletal reorganization consistent with a migratory phenotype. To explore the in vivo relevance of the in vitro effects of these cytokines on endothelium, we studied the angiogenic activity of human G-CSF in the rabbit cornea. G-CSF, but not the heat-inactivated molecule, had definite angiogenic activity, without any sign of inflammatory reactions. G-CSF was less active than bFGF. However, the combination of a nonangiogenic dose of bFGF with G-CSF resulted in an angiogenic response higher than that elicited by either individual cytokines. Thus, G-CSF and GM-CSF induce endothelial cells to express an activation/differentiation program (including proliferation and migration) related to angiogenesis.

MeSH Terms
Animals Cell Division/drug effects Cell Movement/drug effects Cells, Cultured Cytokines/pharmacology Cytoskeleton/drug effects Dose-Response Relationship, Drug Endothelium, Vascular/cytology,physiology Fibroblast Growth Factor 2/pharmacology Fluorescent Antibody Technique Granulocyte Colony-Stimulating Factor/pharmacology Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology Humans In Vitro Techniques Neovascularization, Pathologic Rabbits Wound Healing
Chemicals
Cytokines Fibroblast Growth Factor 2 Granulocyte Colony-Stimulating Factor Granulocyte-Macrophage Colony-Stimulating Factor
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Bussolino F
Dipartimento di Genetica, Biologia, e Chimica Medica, Università di Torino, Italy.
Ziche M
Wang J M
Alessi D
Morbidelli L
Cremona O
Bosia A
Marchisio P C
Mantovani A
References (50)
50 references, click to expand
  1. Nonhematopoietic tumor cells express functional GM-CSF receptors.
    Blood. 1989 Mar;73(4):1033-7 PMID: 2537665
  2. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.
    J Cell Biol. 1989 Jul;109(1):309-15 PMID: 2526131
  3. Cytokines as communication signals between leukocytes and endothelial cells.
    Immunol Today. 1989 Nov;10(11):370-5 PMID: 2514701
  4. How does extracellular matrix control capillary morphogenesis?
    Cell. 1989 Sep 8;58(5):803-5 PMID: 2673531
  5. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion.
    Science. 1989 Dec 8;246(4935):1303-6 PMID: 2588007
  6. Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.
    J Exp Med. 1989 Sep 1;170(3):913-31 PMID: 2769183
  7. American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity.
    Am J Pathol. 1987 Dec;129(3):407-13 PMID: 3322019
  8. The human hematopoietic colony-stimulating factors.
    Science. 1987 Jun 5;236(4806):1229-37 PMID: 3296190
  9. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor.
    Proc Natl Acad Sci U S A. 1987 Apr;84(8):2484-8 PMID: 3550811
  10. Modulation of endothelial cell functions by different molecular species of interleukin 1.
    Blood. 1987 Feb;69(2):695-9 PMID: 3542082
  11. Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells.
    Biochem Biophys Res Commun. 1986 Dec 15;141(2):482-7 PMID: 3541932
  12. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.
    Proc Natl Acad Sci U S A. 1986 May;83(10):3460-4 PMID: 3486418
  13. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor.
    Nature. 1986 Jan 30-Feb 5;319(6052):415-8 PMID: 3484805
  14. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  15. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets.
    Science. 1986 Sep 5;233(4768):1078-80 PMID: 3461562
  16. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
    J Exp Med. 1986 Mar 1;163(3):740-5 PMID: 3753996
  17. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.
    J Clin Invest. 1985 Jan;75(1):11-8 PMID: 3965498
  18. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.
    Proc Natl Acad Sci U S A. 1984 Jun;81(11):3534-8 PMID: 6587368
  19. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
    Proc Natl Acad Sci U S A. 1984 Aug;81(15):4917-21 PMID: 6431411
  20. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.
    J Exp Med. 1983 Apr 1;157(4):1339-53 PMID: 6403654
  21. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
    J Exp Med. 1984 Aug 1;160(2):618-23 PMID: 6332168
  22. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.
    J Immunol Methods. 1980;33(3):239-47 PMID: 6989919
  23. Identification of an inducible endothelial-leukocyte adhesion molecule.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238-42 PMID: 2827173
  24. Production of platelet-activating factor by chick retina.
    J Biol Chem. 1986 Dec 15;261(35):16502-8 PMID: 3023352
  25. Hematopoietic growth factors.
    J Clin Invest. 1987 Jun;79(6):1549-57 PMID: 3034976
  26. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
    J Exp Med. 1987 Nov 1;166(5):1390-404 PMID: 3119758
  27. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
    J Immunol. 1986 Sep 15;137(6):1893-6 PMID: 3091693
  28. Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.
    Proc Natl Acad Sci U S A. 1986 Apr;83(8):2443-7 PMID: 3085094
  29. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.
    J Immunol. 1987 Oct 1;139(7):2439-46 PMID: 3116081
  30. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):9253-7 PMID: 3057504
  31. TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression.
    Cell. 1987 May 8;49(3):415-22 PMID: 3494524
  32. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.
    Science. 1986 Jun 6;232(4755):1250-3 PMID: 2422759
  33. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
    J Biol Chem. 1988 Apr 25;263(12):5797-803 PMID: 3128548
  34. Stimulation of the Na+/H+ exchanger in human endothelial cells activated by granulocyte- and granulocyte-macrophage-colony-stimulating factor. Evidence for a role in proliferation and migration.
    J Biol Chem. 1989 Nov 5;264(31):18284-7 PMID: 2478542
  35. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.
    J Clin Invest. 1986 Jun;77(6):2027-33 PMID: 2872233
  36. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.
    Science. 1986 Apr 4;232(4746):61-5 PMID: 2420009
  37. Enhancement of plasminogen activator activity in cultured endothelial cells by granulocyte colony-stimulating factor.
    J Cell Physiol. 1989 Jan;138(1):192-6 PMID: 2463258
  38. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.
    Nature. 1989 May 4;339(6219):27-30 PMID: 2469962
  39. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate.
    Nature. 1989 Feb 2;337(6206):471-3 PMID: 2464767
  40. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.
    Blood. 1989 Jan;73(1):80-3 PMID: 2462944
  41. Gangliosides promote the angiogenic response.
    Lab Invest. 1989 Dec;61(6):629-34 PMID: 2481152
  42. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.
    Science. 1989 Mar 3;243(4895):1160-5 PMID: 2466335
  43. Keratinocyte growth regulation by the products of immune cells.
    J Exp Med. 1988 Oct 1;168(4):1395-402 PMID: 2459297
  44. Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.
    Am J Pathol. 1988 Dec;133(3):426-33 PMID: 2462353
  45. Inhibitory action of transforming growth factor beta on endothelial cells.
    Proc Natl Acad Sci U S A. 1987 Aug;84(16):5600-4 PMID: 2441387
  46. Structural characterization and biological functions of fibroblast growth factor.
    Endocr Rev. 1987 May;8(2):95-114 PMID: 2440668
  47. Angiogenic factors.
    Science. 1987 Jan 23;235(4787):442-7 PMID: 2432664
  48. Prostacyclin synthesis induced in vascular cells by interleukin-1.
    Science. 1985 Jul 12;229(4709):174-6 PMID: 2409598
  49. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.
    EMBO J. 1989 Dec 1;8(12):3667-76 PMID: 2555171
  50. Recent developments in the cell biology of basic fibroblast growth factor.
    J Cell Biol. 1989 Jul;109(1):1-6 PMID: 2545723
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1991-03-00
Pages
986-95
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC329891
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com